# Memo Therapeutics funding: rounds and investors > Memo Therapeutics has raised $24M across 2 rounds since 2015. Investors include Redalpine, Verve Ventures and KurmaPartners. Every round with its source. Source: https://millionrounds.com/company/memo-therapeutics (Millionrounds; every figure on the page links to its filing or article) Switzerland · [Series C startup](https://millionrounds.com/companies) # Who invested in *Memo Therapeutics* 2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Funding summary Updated 26 Oct 2026 **$24M** raised across 2 rounds since 2015, from 2 sources **$2.3M** Series A **$22M** Series C - **Latest round:** Series C, $22M May 2024 - **Step-up i:** 9.6× - **Investors:** 5 See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2015 2017 2019 2021 2023 **$2.3M** Series A **$22M** Series C - **First round:** Series A, $2.3M - **Biggest round:** $22M - **Between rounds:** 8.8 years ## The rounds - **May 2024** Series C **$22M** *2 new* *1 returning* [Verve Ventures](https://millionrounds.com/fund/verve-ventures) [Redalpine](https://millionrounds.com/fund/redalpine) [KurmaPartners](https://millionrounds.com/fund/kurmapartners) Source recorded - **Jul 2015** Series A **$2.3M** *3 new* [Redalpine](https://millionrounds.com/fund/redalpine) [Zürcher Kantonal Bank](https://millionrounds.com/fund/zurcher-kantonalbank-zkb) [EVA Basel](https://millionrounds.com/fund/eva-basel) From a historical funding record ## Founders and team From Memo Therapeutics's own website: 8 on the team. - **Erik van den Berg** CEO, Board Member - **Lars Spenger** CFO - **Alex Bastian** VP Commercial Strategy - **Kristie Clemmer** VP Clinical Operations - **Matthieu Delincé** VP Technology - **Ellen Rietmann Ahl** Non-Executive Director - **Lisanne van Kouterik** General Counsel - **Michael Cordes** Senior Director Quality Management ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2015 **Series C** 2024 [Redalpine](https://millionrounds.com/fund/redalpine) [Verve Ventures](https://millionrounds.com/fund/verve-ventures) [KurmaPartners](https://millionrounds.com/fund/kurmapartners) [Zürcher Kantonal Bank](https://millionrounds.com/fund/zurcher-kantonalbank-zkb) [EVA Basel](https://millionrounds.com/fund/eva-basel) ## Everyone who backed them [Redalpine](https://millionrounds.com/fund/redalpine) VC firm **2** rounds [Verve Ventures](https://millionrounds.com/fund/verve-ventures) VC firm **1** round [KurmaPartners](https://millionrounds.com/fund/kurmapartners) VC firm **1** round [Zürcher Kantonal Bank](https://millionrounds.com/fund/zurcher-kantonalbank-zkb) Government **1** round [EVA Basel](https://millionrounds.com/fund/eva-basel) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=memo-therapeutics). ## Also claim to have backed them These 3 firms list Memo Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [Pureos Bioventures](https://millionrounds.com/fund/pureos-bioventures) VC firm Per its own site [Adjuvant Capital](https://millionrounds.com/fund/adjuvant-capital) VC firm Per its own site [JFG Life Sciences Foundation](https://millionrounds.com/fund/jfg-life-sciences-foundation) VC firm Per its own site ## Quick answers about Memo Therapeutics ### Who invested in Memo Therapeutics? Memo Therapeutics's investors include Redalpine, Verve Ventures, KurmaPartners, Zürcher Kantonal Bank and EVA Basel. ### How much has Memo Therapeutics raised? Memo Therapeutics has raised $24M across 2 rounds since 2015. ### When did Memo Therapeutics last raise? Memo Therapeutics's most recent round was a Series C of $22M in May 2024. ### What was Memo Therapeutics's biggest round? Its most recent round, $22M in May 2024, is also its largest on record. ### Who backed Memo Therapeutics first? Memo Therapeutics's first round on record, in Jul 2015, was backed by Redalpine, Zürcher Kantonal Bank and EVA Basel. ### What stage is Memo Therapeutics at? Memo Therapeutics's latest named round is a Series C, in May 2024. ### Where is Memo Therapeutics based? Memo Therapeutics is based in Switzerland. ## Companies like Memo Therapeutics In the same sector, and raised in the last eighteen months. [**Nouscom** $191M · Oct 2026](https://millionrounds.com/company/nouscom)[**ADC Therapeutics** $646M · Oct 2026](https://millionrounds.com/company/adc-therapeutics)[**AnaCardio** $89M · Oct 2026](https://millionrounds.com/company/anacardio)[**NovaGo Therapeutics** $40M · Sept 2026](https://millionrounds.com/company/novago-therapeutics)[**Prevision Medicine** $5.4M · Sept 2026](https://millionrounds.com/company/prevision-medicine)[**Medyria** $6.7M · Jul 2026](https://millionrounds.com/company/medyria) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app